HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isabel J Beresford Selected Research

6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamide

12/2013Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists.
6/2007GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isabel J Beresford Research Topics

Disease

2Dementia (Dementias)
12/2013 - 06/2007
2Alzheimer Disease (Alzheimer's Disease)
12/2013 - 06/2007
1Cognitive Dysfunction
06/2007

Drug/Important Bio-Agent (IBA)

26- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA
12/2013 - 06/2007
2Histamine H3 Receptors (Histamine H3 Receptor)IBA
12/2013 - 06/2007
1GSK239512IBA
12/2013

Therapy/Procedure

1Therapeutics
12/2013